Indefinite Delivery Contract 36E79725D0001
Award Date
12/10/24
Last Date to Order
12/9/25
Federal Agency
National Acquisition Center
Awardee
The Harvard Drug Group, L.L.C.
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, contract number 36F79719D0033, to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. This multiple-award contract is under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and has a ceiling value of $452,567,150.00, with a period of performance through May 31, 2025.
The contract is designed to provide the VA, Department of Defense, and other federal healthcare agencies with a...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. to provide pharmaceutical products and medical supplies to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The $6,509,967.70 contract, effective from September 15, 2021 through September 14, 2025, was issued without a set-aside designation.
The contract aims to ensure an uninterrupted...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...
The federal contract IDV award SPE2D219D0077 was issued by the Department of Defense's Defense Logistics Agency (DLA) to The Harvard Drug Group, L.L.C. as a single-award indefinite delivery contract. The $21,366,302.60 contract, awarded on September 5, 2019, is for the manufacture and distribution of a range of pharmaceutical products and medical supplies, including various generic medications, over-the-counter drugs, and topical creams and ointments.
The original competitive solicitation,...
The federal contract IDV award SPE2D019D0002 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The single-award IDV, with a total ceiling value of $9,173,347.42, is for the manufacture and distribution of a wide range of pharmaceutical and medical supply products.
The task orders issued under this IDV include delivery orders for various over-the-counter medications, medical supplies, and prescription...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to The Harvard Drug Group, L.L.C. DBA Major Pharmaceuticals and Rugby Laboratories to supply tamsulosin hydrochloride capsules. The single award contract has a potential value of $62.9 million and a period of performance of June 1, 2022 through May 31, 2023 with four one-year option periods. Delivery will be made to the VA, DoD, Bureau of Prisons, and Indian Health Service through the...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods.
The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA,...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service.
The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026.
The contract will supply aripiprazole tablets in various package sizes to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business.
The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical...